Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YPEG-rhGH (Yipeisheng) vs Norditropin in pediatric growth hormone deficiency
CTR20190901Phase 3Completed
- Sponsor
- Tebao Biotech
- Start
- Jul 2019
- Modality
- PEGylated Peptides → Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegpesen in growth hormone deficiency (GHD), sponsored by Tebao Biotech. Started Jul 2019; status: completed.
02
Drugs
pegpesen
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on CTR20190901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190901.